Robot Asissted Training on Neurodevelopmental Alterations
Key facts
- Who runs it
- University of Valencia
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 9 people enrolled
- Started
- 17 Oct 2024
- Ended
- 15 Oct 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Robot assisted gait training plus conventional physical therapy
- Conventional pjysical therapy
- Record updated
- 16 October 2026
Who can take part
- Age
- 1 year to 16 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Pediactric population with neurodevelopmental disorders who have been diagnosed with cerebral palsy
- With a level IV or V of the GMFCS
- Adapted to the school environment (> 6 months)
- Unable to stand without support
- Receiving conventional physiotherapy (> 6 months)
- Receiving a standing program (standing duration at school: at least 45 minutes/day)
- With ankle orthosis
- Meeting the specific criteria of the exoskeleton manufacturer (ATLAS 2030 Marsibionics https://www.marsibionics.com/): Weight less than 35 kg, Hip width less than 35 cm, Distance from the center of rotation of the hip to that of the knee between 24 and 33 cm, distance from the center of rotation of the knee to that of the ankle between 23 and 32 cm, the ankle can reach close to 90º with or without an orthosis, shoe size less than 33, hip and knee flexion less than or equal to 20º (even after having previously warmed up)
Who cannot take part
- Children treated surgically within the 1-year period prior to the evaluation date
- Uncontrolled epilepsy: active epilepsy resistant to medication
- Severe spinal deformity
- Severe hip dysplasia
- Knee and hip flexion greater than 20º
- Skin inflammation and open skin lesions around the trunk or limbs
- Pacemaker, defibrillator or osteosynthesis material carriers
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this randomized crossover clinical trial is to determine the effect of robot assisted gait training combined with physiotherapy on body composition and functional variables in a pediatric population with neurodevelopmental disorders.The main questions to answer are:
Read full original descriptionShow less
* Does this treatment improve body composition parameters? * Does the treatment help maintaining functionality and without causing discomfort or pain?
Participants will perform 2 weekly physiotherapy sessions for 8 weeks, then there will be 4 weeks of washout, afer which each patient will cross over to the other group for 8 more weeks.
The 2 groups in the trial
- robot assisted gait training plus conventional physical therapyTreatment being tested
Participants will complete 8 weeks of intervention of robot assisted gait training plus conventional physical therapy.
- Conventional physical therapyExisting treatment, for comparison
Participants will complete 8 weeks of conventional therapy.
Treatment: Conventional pjysical therapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Physiotherapy Based on Robot Assited Gait Training on Body Composition and Functional Variables in Pediatric Patient With Neurodevelopmental Alterations: Randomized and Crossover Clinical Trial
- Record updated
- 16 October 2026